SCHEMBL19620226

SCHEMBL19620226

C=CC(=O)OC/C=C/COC(=O)C=C

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 10/20 0.54
ALDH1A1 P00352 8/20 0.54
TP53 P04637 3/20 0.54
HIF1A Q16665 3/20 0.54
CYP3A4 P08684 3/20 0.54
HSD17B10 Q99714 1/20 0.54
MAPK1 P28482 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HPGD P15428 1/20 0.48
THRB P10828 3/20 0.39
MAPT P10636 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
LMNA P02545 1/20 0.33
FGFR4 P22455 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
APP P05067 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19846628 1.00 TSHR (0.54) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL29417881 1.00 TSHR (0.54) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL11700557 0.91 TSHR (0.52) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL11700563 0.91 TSHR (0.52) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL2829746 0.89 TSHR (0.45) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL5586275 0.89 TSHR (0.50) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL7718104 0.89 TSHR (0.45) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL2606268 0.89 TSHR (0.45) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL2829742 0.89 TSHR (0.45) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL10608809 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110366703-B Substrate pretreatment composition for nanoimprint lithography 佳能株式会社 2023-11-14 CN disclosed
CN-111708260-B Substrate pretreatment to reduce fill time in nanoimprint lithography 佳能株式会社 2023-11-10 CN disclosed
EP-4097155-A1 ACTINICALLY-CROSSLINKABLE POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF Clearlab SG Pte Ltd (SG) 2022-12-07 EP disclosed
EP-3359119-B1 DENTAL COMPOSITION DENTSPLY DETREY GMBH (DE) 2021-12-29 EP disclosed
US-11000454-B2 Dental composition DENTSPLY SIRONA INC. (US) 2021-05-11 US disclosed
US-20190117523-A1 DENTAL COMPOSITION DENTSPLY SIRONA INC. (US) 2019-04-25 US disclosed
US-20180037688-A1 CURABLE COMPOSITION FOR IMPRINTS, CURED PRODUCT, PATTERN FORMING METHOD, LITHOGRAPHY METHOD, PATTERN AND LITHOGRAPHY MASK FUJIFILM CORPORATION (JP) 2018-02-08 US disclosed
WO-2017198840-A1 DENTAL COMPOSITION DENTSPLY DETREY GMBH (DE) 2017-11-23 WO disclosed
EP-3246001-A1 DENTAL COMPOSITION DENTSPLY DETREY GmbH (DE) 2017-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11000454-B2 Dental composition PPIP5K2, INPP5D, DCPS TSHR 4113/4885ALDH1A1 1990/4885TP53 2225/4885
US-20190117523-A1 DENTAL COMPOSITION PPIP5K2, INPP5D, DCPS TSHR 4113/4885ALDH1A1 1990/4885TP53 2225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.